Biotage AB (publ) (STO: BIOT)

Market Cap	10.77B
Revenue (ttm)	2.12B
Net Income (ttm)	257.00M
Shares Out	80.05M
EPS (ttm)	3.20
PE Ratio	42.04
Forward PE	35.34
Dividend	1.60 (1.19%)
Ex-Dividend Date	Apr 26, 2024

Volume	168,550
Average Volume	138,074
Open	136.00
Previous Close	136.00
Day's Range	133.50 - 137.30
52-Week Range	133.20 - 202.20
Beta	0.90
RSI	31.56
Earnings Date	Feb 19, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 674
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2023, Biotage AB's revenue was 1.86 billion, an increase of 18.90% compared to the previous year's 1.57 billion. Earnings were 246.00 million, a decrease of -8.21%.